Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: Clinical outcome and length of hospitalization

Clinical Infectious Diseases

Volumn 34, Issue 12, 2002, Pages 1600-1606

  Blot, Stijn ^a   Vandewoude, Koenraad ^a   De Bacquer, Dirk ^b   Colardyn, Francis ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN;

ACINETOBACTER; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; COMORBIDITY; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SERRATIA; TREATMENT OUTCOME;

BACTEREMIA; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; DRUG RESISTANCE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037097652     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340616     Document Type: Article

References (27)

1. Antibiotic usage in an intensive care unit in a Danish university hospital
2. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study
3. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States
4. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
5. APACHE II: A severity of disease classification system
6. Extended-spectrum plasmid-mediated beta-lactamases
7. Failure of selective digestive decontamination (SDD) to control an epidemic of colonization by extended spectrum β-lactamase-producing Klebsiella pneumoniae (CAZ)
8. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
9. Antibiotic resistance in the intensive care unit
10. Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent
11. Staphylococcus aureus infections
12. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia
13. A nationwide multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
14. Polymicrobial bacteremia: Clinical and microbiologic patterns
15. Impact and pattern of gram-negative bacteraemia during 6 y at a large university hospital
16. Polymicrobial bacteremia in critically ill patients
17. Clinical significance and impact on mortality of ESBL-producing gram-negative isolates in nosocomial bacteremia
18. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: A case controlled study
19. Comparison of survival in patients having bacteremia with and without extended-spectrum betalactamase producing Enterobacteriaceae (ESBLPE)
20. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
21. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
22. The influence of inadequate antimicrobial treatment of blood stream infections on patient outcomes in the ICU setting
23. Pseudomonas bacteremia: Retrospective analysis of 410 episodes
24. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment
25. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units
26. Infection control in ICU: Back (forward) to surveillance samples